Sign in

Private company

TODOS MEDICAL LTD.

TODOS MEDICAL LTD. is a surgical and medical instruments and apparatus company.1

Last updated Oct 21, 2026.

Overview

  • IndustrySurgical & Medical Instruments & Apparatus1
  • HeadquartersL31
  • Incorporated inIsrael2
  • Business address1 Hamada Street, Rehovot, L3 76703012
  • Filer categoryNon-accelerated filer, Smaller reporting company2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2021

35.8%Gross margin3
-75.9%Operating margin3
-354.2%Net margin3
134.9%Revenue growth, 20213
-$12.3MFree cash flow3

Where the money goes

Where each dollar of revenue went, fiscal 2021

  • Cost of revenue64¢$7.8M
  • Research and development7¢$824.0K
  • Other costs29¢$3.6M

Out of $12.2M in revenue.3 The company lost money this year.

Financial statements

Revenue43$12.2M in 2021+21739% since 2016
0$5.0M$10.0M$15.0M2016: $56.0K$56.0K20162020: $5.2M$5.2M2020+9198%2021: $12.2M$12.2M2021+135%
Gross profit3$4.4M in 2021+216% since 2020
0$2.0M$4.0M$6.0M2020: $1.4M$1.4M20202021: $4.4M$4.4M2021+216%
Operating income53-$9.3M in 2021+164% since 2019
-$15.0M-$10.0M-$5.0M02019: -$3.5M-$3.5M20192020: -$14.3M-$14.3M2020+306%2021: -$9.3M-$9.3M2021−35%
Net income64753-$43.3M in 2021+5192% since 2015
-$60.0M-$40.0M-$20.0M02015: -$818.5K-$818.5K20152016: -$653.5K-$653.5K2016−20%2017: -$2.7M-$2.7M2017+309%2018: -$457.5K-$457.5K2018−83%2019: -$11.8M-$11.8M2019+2482%2020: -$29.8M-$29.8M2020+152%2021: -$43.3M-$43.3M2021+45%
Fiscal year2015201620172018201920202021
Revenue$56.0K4$5.2M3$12.2M3
Cost of revenue$3.8M3$7.8M3
Gross profit$1.4M3$4.4M3
Research and development$374.0K6$317.9K4$720.5K7$459.2K7$756.0K5$9.9M3$824.0K3
Operating expenses-$9.3M3
Operating income-$3.5M5-$14.3M3-$9.3M3
Net income-$818.5K6-$653.5K4-$2.7M7-$457.5K7-$11.8M5-$29.8M3-$43.3M3

Compare TODOS MEDICAL LTD. with another company

Corporate structure

TODOS MEDICAL LTD. sits at the top of its group. 1 entity on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of TODOS MEDICAL LTD.

  • TODOS MEDICAL LTD. L3

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What TODOS MEDICAL LTD. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$3.6M3 Dec 31, 2021$2.2M3 Dec 31, 2020+61.1%
Accumulated depreciation$485.0K3 Dec 31, 2021$209.0K5 Dec 31, 2020+132.1%
Property and equipment, net$2.0M3 Dec 31, 2021$2.0M3 Dec 31, 2020+2.3%
Operating-lease assets (leased space)$143.0K3 Dec 31, 2021

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$189.0K3 Dec 31, 2021$935.0K3 Dec 31, 2020−79.8%
Stakes in other companies (equity method)$1.6M3 Dec 31, 2020

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$6.2M3 Dec 31, 2021
Intangible assets, net (excluding goodwill)$1.5M3 Dec 31, 2021

Inventory

ItemLatestA year beforeChange
Inventory, total$1.6M3 Dec 31, 2021$536.0K3 Dec 31, 2020+199.1%

Leadership

Who has led TODOS MEDICAL LTD., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Gerald Commissiong2021–2023
2025
Board members and other officers (1)

Timeline

  1. Mar 31, 20238-K Entered a material agreement12
  2. Sep 30, 20228-K Shareholder vote13
  3. Sep 29, 20228-K Entered a material agreement14
  4. Sep 13, 20228-K Entered a material agreement; New debt or obligation; Other events15
  5. Sep 13, 20228-K Entered a material agreement; New debt or obligation16
  6. Sep 1, 20228-K Entered a material agreement; New debt or obligation; Other events17
  7. Aug 10, 20228-K Other events18
  8. Aug 5, 20228-K Other events19
  9. Apr 1, 20228-K Results of operations20
  10. Mar 17, 20228-K Entered a material agreement; Unregistered sale of shares21
  11. Nov 29, 20218-K Entered a material agreement; New debt or obligation; Unregistered sale of shares22
  12. Nov 16, 20218-K Results of operations23
  13. Jul 8, 2021New chief executive Gerald Commissiong becomes CEO11

Calendar

When it reported results

  1. Apr 1, 2022Reported quarterly or annual results20
  2. Nov 16, 2021Reported quarterly or annual results23

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

38 filings to the SEC since October 2021: 1 annual reports, 4 quarterly reports, 13 major events, 2 insider forms, 4 large holders, 14 other. The latest 20:

  1. Jul 17, 202315-12G EDGAR
  2. Jun 13, 2023SEC STAFF ACTION EDGAR
  3. May 16, 2023NT 10-Q EDGAR
  4. Mar 31, 20238-K EDGAR
  5. Mar 31, 2023NT 10-K EDGAR
  6. Mar 29, 20234 EDGAR
  7. Mar 15, 2023SC 13D/A EDGAR
  8. Feb 17, 2023SC 13D EDGAR
  9. Nov 14, 202210-Q EDGAR
  10. Sep 30, 20228-K EDGAR
  11. Sep 29, 20228-K EDGAR
  12. Sep 13, 20228-K EDGAR
  13. Sep 13, 20228-K/A EDGAR
  14. Sep 1, 20228-K EDGAR
  15. Aug 24, 20224 EDGAR
  16. Aug 22, 202210-Q EDGAR
  17. Aug 22, 2022DEFA14A EDGAR
  18. Aug 22, 2022DEF 14A EDGAR
  19. Aug 15, 2022NT 10-Q EDGAR
  20. Aug 12, 2022PRE 14A EDGAR

The 38 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

2 open-market trades by officers, directors and large owners since October 2021: 2 buys and 0 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Mar 28, 2023COMMISSIONG GERALDCEO and DirectorBuy5,000,000Form 4
Aug 24, 2022COMMISSIONG GERALDCEO and DirectorBuy1,000,000$0.03$30.0KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How TODOS MEDICAL LTD. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARTODOS MEDICAL LTD.1
  • CIK0001645260
  • Filer statusNon-accelerated filer<br>smaller reporting company1
  • Incorporated inIsrael1
  • Fiscal year endsDecember 311
  • Industry code (SIC)3841 Surgical & Medical Instruments & Apparatus1
  • Business address1 Hamada Street, Rehovot, L3 76703011
  • Phone9725463806661
  • Shares outstanding1,408,127,143 as of Nov 14, 20229
  • Public float$49.2M as of Dec 31, 20213
  • On EDGAR sinceAug 25, 20151
  • Filings178 in all: 6-K (47), 8-K (25), F-1/A (13), UPLOAD (11), SC 13G (9), CORRESP (8), 10-Q (6), 4 (5)1
    All 37 form types

    20-F (4), 8-K/A (4), EFFECT (4), F-1 (4), NT 10-Q (4), 424B4 (3), 10-K (2), DRS/A (2), DRSLTR (2), NT 10-K (2), RW (2), S-1 (2), S-1/A (2), SC 13D (2), 15-12G (1), 20-F/A (1), 3 (1), 6-K/A (1), 8-A12G (1), D (1), DEF 14A (1), DEFA14A (1), DRS (1), NT 20-F (1), POS AM (1), PRE 14A (1), SC 13D/A (1), SC 13G/A (1), SEC STAFF ACTION (1)

  • Latest filingsAnnual report (10-K) Mar 31, 2022
    Quarterly report (10-Q) Nov 14, 2022
    Proxy statement (DEF 14A) Aug 22, 2022
    Latest 8-K (8-K) Mar 31, 2023

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
    SEC EDGAROther events
  19. 19
    SEC EDGAROther events
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25